Common heart & bone supplements tested for rare eye disease
NCT ID NCT07400757
Summary
This study aims to see if adding two common supplements—a cholesterol-lowering statin and vitamin D—to standard care can help calm the inflammation and reduce symptoms in people with active Thyroid Eye Disease. Researchers will compare four groups over 24 weeks: standard care alone, or standard care plus statin, plus vitamin D, or both. The goal is to find safer add-on treatments that can better control this autoimmune eye condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE (TED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taipei Veterans General Hospital
Taipei, Taiwan, 11217, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.